Serveur d'exploration COVID et hydrochloroquine - Exploration (Accueil)

Index « Pays » - entrée « France »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Finlande < France < Gabon  Facettes :

List of bibliographic references indexed by France

Number of relevant bibliographic references: 212.
[0-20] [0 - 20][0 - 50][20-40]
Ident.Authors (with country if any)Title
000004 (2021) Stéphane Honoré [France] ; Philippe Gautret [France]Reply to Alizazgar J. Dangers of the use of hydroxychloroquine and azithromycin combination in COVID-19 patients.
000011 (2021) Matthieu Million [France] ; Audrey Giraud-Gatineau [France] ; Jean-Christophe Lagier [France] ; Philippe Parola [France] ; Philippe Gautret [France] ; Didier Raoult [France]Reply to Lebeaux D, Revest M. No evidence of clinical benefits of early treatment of COVID-19 patients with hydroxychloroquine and azithromycin.
000019 (2021) B. Lefrère [France] ; A. Barbaud [France] ; M. Bagot [France] ; E. Bourgogne [France][Tonic water and quinine-a bicentennial booming cocktail].
000073 (2021) Alexis Lacout [France] ; Valere Lounnas [Allemagne] ; Christian Perronne [France]Timing and dosage may be the key in the realisation of hydroxychloroquine + azithromycin treatment benefit in Covid-19 elderly patients.
000087 (2021) Romain Lutaud [France] ; Dimiti Scronias [France] ; Jeremy Ward [France] ; Pierre Verger [France]The hydroxychloroquine debate: a therapeutic dilemma for general practitioners.
000104 (2021) Farah Daou [Liban] ; Gretta Abou-Sleymane [Liban] ; Danielle A. Badro [Liban] ; Nagham Khanafer [France] ; Mansour Tobaiqy [Arabie saoudite] ; Achraf Al Faraj [Liban]The History, Efficacy, and Safety of Potential Therapeutics: A Narrative Overview of the Complex Life of COVID-19.
000130 (2021) Yudibeth Sixto-L Pez [Mexique] ; José Correa-Basurto [Mexique] ; Martiniano Bello [Mexique] ; Bruno Landeros-Rivera [France] ; Jose Antonio Garz N-Tiznado [Mexique] ; Sarita Monta O [Mexique]Structural insights into SARS-CoV-2 spike protein and its natural mutants found in Mexican population.
000135 (2021) Baptiste Maille [France] ; Marie Wilkin [France] ; Matthieu Million [France] ; Noémie Rességuier [France] ; Frédéric Franceschi [France] ; Linda Koutbi-Franceschi [France] ; Jérôme Hourdain [France] ; Elisa Martinez [France] ; Maxime Zabern [France] ; Christophe Gardella [France] ; Hervé Tissot-Dupont [France] ; Jagmeet P. Singh [États-Unis] ; Jean-Claude Deharo [France] ; Laurent Fiorina [France]Smartwatch Electrocardiogram and Artificial Intelligence for Assessing Cardiac-Rhythm Safety of Drug Therapy in the COVID-19 Pandemic. The QT-logs study.
000147 (2021) Anthony Touafchia [France] ; Haleh Bagheri [France] ; Didier Carrié [France] ; Geneviève Durrieu [France] ; Agnès Sommet [France] ; Laurent Chouchana [France] ; François Montastruc [France]Serious bradycardia and remdesivir for coronavirus 2019 (COVID-19): a new safety concerns.
000150 (2021) Philippe Gautret [France] ; Stéphane Honoré [France] ; Jean-Christophe Lagier [France] ; Didier Raoult [France]Safety profile of hydroxychloroquine and azithromycin combined treatment in COVID-19 patients.
000156 (2021) Etienne Meriglier [France] ; Claire Rivoisy [France] ; Mojgan Hessamfar [France] ; Noelle Bernard [France] ; Ines Aureau [France] ; Joelle Lapoirie [France] ; Anne Contis [France] ; Frédéric Sacher [France] ; Benjamin Sacristan [France] ; Marin Lahouati [France] ; Stéphane Pedeboscq [France] ; Marie-Anne Vandenhende [France] ; Stéphane Bouchet [France] ; Fabrice Bonnet [France]Safety of hydroxychloroquine and darunavir or lopinavir in COVID-19 infection.
000172 (2021) Fanny Onodi [France] ; Lucie Bonnet-Madin [France] ; Laurent Meertens [France] ; Léa Karpf [France] ; Justine Poirot [France] ; Shen-Ying Zhang [France, États-Unis] ; Capucine Picard [France] ; Anne Puel [France, États-Unis] ; Emmanuelle Jouanguy [France, États-Unis] ; Qian Zhang [États-Unis] ; Jérôme Le Goff [France] ; Jean-Michel Molina [France] ; Constance Delaugerre [France] ; Jean-Laurent Casanova [France, États-Unis] ; Ali Amara [France] ; Vassili Soumelis [France]SARS-CoV-2 induces human plasmacytoid predendritic cell diversification via UNC93B and IRAK4.
000173 (2021) Fanny Onodi [France] ; Lucie Bonnet-Madin [France] ; Laurent Meertens [France] ; Léa Karpf [France] ; Justine Poirot [France] ; Shen-Ying Zhang [États-Unis] ; Capucine Picard ; Anne Puel [États-Unis] ; Emmanuelle Jouanguy [États-Unis] ; Qian Zhang [États-Unis] ; Jérôme Le Goff [France] ; Jean-Michel Molina [France] ; Constance Delaugerre [France] ; Jean-Laurent Casanova [États-Unis] ; Ali Amara [France] ; Vassili Soumelis [France]SARS-CoV-2 induces human plasmacytoid pre-dendritic cell diversification via UNC93B and IRAK4.
000182 (2021) Philippe Guilpain [France] ; Clément Le Bihan [France] ; Vincent Foulongne [France] ; Patrice Taourel [France] ; Nathalie Pansu [France] ; Alexandre Thibault Jacques Maria [France] ; Boris Jung [France] ; Romaric Larcher [France] ; Kada Klouche [France] ; Vincent Le Moing [France]Rituximab for granulomatosis with polyangiitis in the pandemic of covid-19: lessons from a case with severe pneumonia.
000192 (2021) Alexis Mathian [France] ; Zahir Amoura [France]Response to: 'Are patients with systemic lupus erythematosus at increased risk for COVID-19?' by Favalli et al.
000193 (2021) Philippe Gautret [France] ; Van Thuan Hoang [Viêt Nam] ; Hervé Chaudet [France] ; Jean-Christophe Lagier [France] ; Didier Raoult [France]Response to uncertain effect of hydroxychloroquine and azithromycin on SARS-CoV-2 viral load.
000194 (2021) Philippe Gautret [France] ; Van Thuan Hoang [Viêt Nam] ; Stéphane Honoré [France] ; Yanis Roussel [France] ; Matthieu Million [France] ; Jean-Christophe Lagier [France] ; Didier Raoult [France]Response to the use of hydroxychloroquine in combination with azithromycin for patients with COVID-19 is not supported by recent literature.
000195 (2021) Philippe Gautret [France] ; Van Thuan Hoang [Viêt Nam] ; Jean-Christophe Lagier [France] ; Didier Raoult [France]Response to effect estimation of hydroxychloroquine for COVID-19: a secondary analysis of an open label non-randomized clinical trial.
000202 (2021) Van Thu Nguyen [France] ; Philippe Rivière [France] ; Pierre Ripoll [France] ; Julien Barnier [France] ; Romain Vuillemot [France] ; Gabriel Ferrand [France] ; Sarah Cohen-Boulakia [France] ; Philippe Ravaud [France] ; Isabelle Boutron [France]Research response to coronavirus disease 2019 needed better coordination and collaboration: a living mapping of registered trials.
000210 (2021) David Hajage [France] ; Valérie Pourcher [France] ; Olivier Paccoud [France] ; Alexandre Bleibtreu [France] ; Eric Caumes [France] ; Florence Tubach [France]Reply to Million et al.
000215 (2021) Alexandre O. Gérard [France] ; Audrey Laurain [France] ; Audrey Fresse [France] ; Nadège Parassol [France] ; Marine Muzzone [France] ; Fanny Rocher [France] ; Vincent L M. Esnault [France] ; Milou-Daniel Drici [France]Remdesivir and Acute Renal Failure: A Potential Safety Signal From Disproportionality Analysis of the WHO Safety Database.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/AffPays.i -k "France" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/AffPays.i  \
                -Sk "France" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidChloroV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    AffPays.i
   |clé=    France
}}

Wicri

This area was generated with Dilib version V0.6.38.
Data generation: Sat May 22 17:02:32 2021. Site generation: Sat May 22 17:06:52 2021